{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:56:59Z","timestamp":1778684219217,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":21,"publisher":"Springer New York","isbn-type":[{"value":"9781461432081","type":"print"},{"value":"9781461432098","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-1-4614-3209-8_55","type":"book-chapter","created":{"date-parts":[[2014,3,24]],"date-time":"2014-03-24T07:46:47Z","timestamp":1395647207000},"page":"435-440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Complement Regulatory Protein CD59: Insights into Attenuation of Choroidal Neovascularization"],"prefix":"10.1007","author":[{"given":"Gloriane","family":"Schnabolk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e4rbel","family":"Rohrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"key":"55_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/07853890600946724","volume":"38","author":"KM Gehrs","year":"2006","unstructured":"Gehrs KM, Anderson DH, Johnson LV, Hageman GS (2006) Age-related macular degeneration- emerging pathogenetic and therapeutic concepts. Ann of Med 38:450\u2013471","journal-title":"Ann of Med"},{"key":"55_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1350-9462(01)00010-6","volume":"20","author":"GS Hageman","year":"2001","unstructured":"Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch\u2019s membrane interface in aging and age-related macular degeneration. Prog Retinal Eye Res 20:705\u2013732","journal-title":"Prog Retinal Eye Res"},{"key":"55_CR3","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1006\/exer.2001.1094","volume":"73","author":"LV Johnson","year":"2001","unstructured":"Johnson LV, Leitner WP, Staples MK, Anderson DH (2001) Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res 73:887\u2013896","journal-title":"Exp Eye Res"},{"key":"55_CR4","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1073\/pnas.0501536102","volume":"102","author":"GS Hageman","year":"2005","unstructured":"Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI et al (2005) A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102:7227\u20137232","journal-title":"Proc Natl Acad Sci U S A"},{"key":"55_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.bi.57.070188.001541","volume":"57","author":"HJ Muller-Eberhard","year":"1988","unstructured":"Muller-Eberhard HJ (1988) Molecular organization and function of the complement system. Ann Rev Biochem 57:321\u2013347","journal-title":"Ann Rev Biochem"},{"key":"55_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.170.3.637","volume":"170","author":"A Davies","year":"1989","unstructured":"Davies A, Simmons DL, Hale G, Harrison RA, Tighe H, Lachmann PJ et al (1989) CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 170:637\u2013654","journal-title":"J Exp Med"},{"key":"55_CR7","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1016\/S0021-9258(18)42266-1","volume":"267","author":"H Ninomiya","year":"1992","unstructured":"Ninomiya H, Sims PJ (1992) The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the \u201cb\u201ddomain of C9. J Biol Chem 267:13675\u201313680","journal-title":"J Biol Chem"},{"key":"55_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s00335-001-2060-8","volume":"12","author":"X Qin","year":"2001","unstructured":"Qin X, Miwa T, Aktas H, Gao M, Lee C, Qian YM et al (2001) Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b. Mamm Genome 12:582\u2013589","journal-title":"Mamm Genome"},{"key":"55_CR9","doi-asserted-by":"crossref","unstructured":"Ebrahimi KB, Fijalkowski N, Cano M, Handa JT (2012) Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration. J Pathol (in press)","DOI":"10.1002\/path.4128"},{"key":"55_CR10","first-page":"495","volume":"85","author":"J Hakulinen","year":"1995","unstructured":"Hakulinen J, Meri S (1995) Shedding and enrichment of the glycolipid-anchored complement lysis inhibitor protectin (CD59) into milk fat globules. Immunology 85:495\u2013501","journal-title":"Immunology"},{"key":"55_CR11","first-page":"532","volume":"65","author":"S Meri","year":"1991","unstructured":"Meri S, Waldmann H, Lachmann PJ (1991) Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest 65:532\u2013537","journal-title":"Lab Invest"},{"key":"55_CR12","first-page":"34","volume":"82","author":"Y Sugita","year":"1994","unstructured":"Sugita Y, Ito K, Shiozuka K, Suzuki H, Gushima H, Tomita M et al (1994) Recombinant soluble CD59 inhibits reactive haemolysis with complement. Immunology 82:34\u201341","journal-title":"Immunology"},{"key":"55_CR13","doi-asserted-by":"publisher","first-page":"5750","DOI":"10.4049\/jimmunol.174.9.5750","volume":"174","author":"C He","year":"2005","unstructured":"He C, Imai M, Song H, Quigg RJ, Tomlinson S (2005) Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. J Immunol 174:5750\u20135757","journal-title":"J Immunol"},{"key":"55_CR14","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.4049\/jimmunol.178.3.1783","volume":"178","author":"NS Bora","year":"2007","unstructured":"Bora NS, Kaliappan S, Jha P, Xu Q, Sivasankar B, Harris CL et al (2007) CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. J Immunol 178:1783\u20131790","journal-title":"J Immunol"},{"key":"55_CR15","doi-asserted-by":"publisher","first-page":"33826","DOI":"10.1074\/jbc.M110.153130","volume":"285","author":"NS Bora","year":"2010","unstructured":"Bora NS, Jha P, Lyzogubov VV, Kaliappan S, Liu J, Tytarenko RG et al (2010) Recombinant membrane-targeted form of CD59 inhibits the growth of choroidal neovascular complex in mice. J Biol Chem 285:33826\u201333833","journal-title":"J Biol Chem"},{"key":"55_CR16","doi-asserted-by":"publisher","first-page":"e19078","DOI":"10.1371\/journal.pone.0019078","volume":"6","author":"SM Cashman","year":"2011","unstructured":"Cashman SM, Ramo K, Kumar-Singh R (2011) A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration. PloS One 6:e19078","journal-title":"PloS One"},{"key":"55_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0161-5890(84)90103-2","volume":"21","author":"RJ Leatherbarrow","year":"1984","unstructured":"Leatherbarrow RJ, Dwek RA (1984) Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay. Mol Immunol 21:321\u2013327","journal-title":"Mol Immunol"},{"key":"55_CR18","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1172\/JCI25208","volume":"115","author":"C Atkinson","year":"2005","unstructured":"Atkinson C, Song H, Lu B, Qiao F, Burns TA, Holers VM et al (2005) Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J Clin Invest 115:2444\u20132453","journal-title":"J Clin Invest"},{"key":"55_CR19","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1167\/iovs.08-2222","volume":"50","author":"B Rohrer","year":"2009","unstructured":"Rohrer B, Long Q, Coughlin B, Wilson RB, Huang Y, Qiao F et al (2009) A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age- related macular degeneration. Invest Ophthalmol Vis Sci 50:3056\u20133064","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"55_CR20","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1172\/JCI17348","volume":"111","author":"H Song","year":"2003","unstructured":"Song H, He C, Knaak C, Guthridge JM, Holers VM, Tomlinson S (2003) Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. J Clin Invest 111:1875\u20131885","journal-title":"J Clin Invest"},{"key":"55_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1089\/jop.2011.0212","volume":"28","author":"B Rohrer","year":"2012","unstructured":"Rohrer B, Coughlin B, Bandyopadhyay M, Holers VM (2012) Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization. J Ocular Pharmacol Ther 28:402\u2013409","journal-title":"J Ocular Pharmacol Ther"}],"container-title":["Advances in Experimental Medicine and Biology","Retinal Degenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-3209-8_55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T03:16:47Z","timestamp":1676863007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4614-3209-8_55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9781461432081","9781461432098"],"references-count":21,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-3209-8_55","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"25 March 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}